Abstract
D&MD's new Pain Therapeutics market analysis report focuses on new advances in
drug discovery and development. The report provides a background on pain,
current therapies and research and development in the area. Profiles of
companies with major pain programs include Abbott Laboratories, AstraZeneca,
GlaxoSmithKline, GW Pharmaceuticals, Johnson & Johnson, Merck & Co., Neuromed
Pharmaceuticals, Novartis, Pfizer, Vernalis, VistaGen Therapeutics, Xenome and
more. In-depth interviews with industry leaders provide specific case studies
from both biotech and academia that give a sense of what's really going on in
the trenches.
| 
View Cart
